Literature DB >> 15356129

Expression of the glucocorticoid receptor from the 1A promoter correlates with T lymphocyte sensitivity to glucocorticoid-induced cell death.

Jared F Purton1, Julie A Monk, Douglas R Liddicoat, Konstantinos Kyparissoudis, Samy Sakkal, Samantha J Richardson, Dale I Godfrey, Timothy J Cole.   

Abstract

Glucocorticoid (GC) hormones cause pronounced T cell apoptosis, particularly in immature thymic T cells. This is possibly due to tissue-specific regulation of the glucocorticoid receptor (GR) gene. In mice the GR gene is transcribed from five separate promoters designated: 1A, 1B, 1C, 1D, and 1E. Nearly all cells express GR from promoters 1B-1E, but the activity of the 1A promoter has only been reported in the whole thymus or lymphocyte cell lines. To directly assess the role of GR promoter use in sensitivity to glucocorticoid-induced cell death, we have compared the activity of the GR 1A promoter with GC sensitivity in different mouse lymphocyte populations. We report that GR 1A promoter activity is restricted to thymocyte and peripheral lymphocyte populations and the cortex of the brain. The relative level of expression of the 1A promoter to the 1B-1E promoters within a lymphocyte population was found to directly correlate with susceptibility to GC-induced cell death, with the extremely GC-sensitive CD4+CD8+ thymocytes having the highest levels of GR 1A promoter activity, and the relatively GC-resistant alphabetaTCR+CD24(int/low) thymocytes and peripheral T cells having the lowest levels. DNA sequencing of the mouse GR 1A promoter revealed a putative glucocorticoid-response element. Furthermore, GR 1A promoter use and GR protein levels were increased by GC treatment in thymocytes, but not in splenocytes. These data suggest that tissue-specific differences in GR promoter use determine T cell sensitivity to glucocorticoid-induced cell death. Copyright 2004 The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15356129     DOI: 10.4049/jimmunol.173.6.3816

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  33 in total

1.  Rapamycin improves lymphoproliferative disease in murine autoimmune lymphoproliferative syndrome (ALPS).

Authors:  David T Teachey; Dana A Obzut; Kelly Axsom; John K Choi; Kelly C Goldsmith; Junior Hall; Jessica Hulitt; Catherine S Manno; John M Maris; Nicholas Rhodin; Kathleen E Sullivan; Valerie I Brown; Stephan A Grupp
Journal:  Blood       Date:  2006-06-06       Impact factor: 22.113

2.  Incidence of infections associated with oral glucocorticoid dose in people diagnosed with polymyalgia rheumatica or giant cell arteritis: a cohort study in England.

Authors:  Jianhua Wu; Adam Keeley; Christian Mallen; Ann W Morgan; Mar Pujades-Rodriguez
Journal:  CMAJ       Date:  2019-06-24       Impact factor: 8.262

3.  Molecular and cellular mechanisms of Mycobacterium avium-induced thymic atrophy.

Authors:  Margarida Borges; Palmira Barreira-Silva; Manuela Flórido; Michael B Jordan; Margarida Correia-Neves; Rui Appelberg
Journal:  J Immunol       Date:  2012-08-24       Impact factor: 5.422

4.  Interleukin-22 drives endogenous thymic regeneration in mice.

Authors:  Jarrod A Dudakov; Alan M Hanash; Robert R Jenq; Lauren F Young; Arnab Ghosh; Natalie V Singer; Mallory L West; Odette M Smith; Amanda M Holland; Jennifer J Tsai; Richard L Boyd; Marcel R M van den Brink
Journal:  Science       Date:  2012-03-01       Impact factor: 47.728

5.  Glucocorticoid-induced apoptosis of healthy and malignant lymphocytes.

Authors:  Lindsay K Smith; John A Cidlowski
Journal:  Prog Brain Res       Date:  2010       Impact factor: 2.453

Review 6.  Thymus: the next (re)generation.

Authors:  Mohammed S Chaudhry; Enrico Velardi; Jarrod A Dudakov; Marcel R M van den Brink
Journal:  Immunol Rev       Date:  2016-05       Impact factor: 12.988

7.  Expression of 11beta-hydroxysteroid dehydrogenase 2 contributes to glucocorticoid resistance in lymphoblastic leukemia cells.

Authors:  Shuji Sai; Yuichi Nakagawa; Rie Yamaguchi; Masako Suzuki; Kimiyoshi Sakaguchi; Shuichi Okada; Jonathan R Seckl; Takehiko Ohzeki; Karen E Chapman
Journal:  Leuk Res       Date:  2011-07-26       Impact factor: 3.156

Review 8.  Infection Risk and Safety of Corticosteroid Use.

Authors:  Jameel Youssef; Shannon A Novosad; Kevin L Winthrop
Journal:  Rheum Dis Clin North Am       Date:  2015-10-24       Impact factor: 2.670

Review 9.  Glucocorticoids in T cell apoptosis and function.

Authors:  M J Herold; K G McPherson; H M Reichardt
Journal:  Cell Mol Life Sci       Date:  2006-01       Impact factor: 9.261

Review 10.  Idiopathic nephrotic syndrome: the EBV hypothesis.

Authors:  Claire Dossier; Agnès Jamin; Georges Deschênes
Journal:  Pediatr Res       Date:  2016-09-28       Impact factor: 3.756

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.